Product logins

Find logins to all Clarivate products below.


Coronary Artery Bypass Graft Devices | US | 2016 | Market Analysis

The US CABG device market is highly mature and faces challenges from competing treatment options such as PCI and increasing cost-consciousness among health care facilities. As a result, the market for these devices will contract slightly through 2024.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for CABGdevices in the US, with market projections across a 10-year period.

Related Medtech Insights Reports

Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will grow modestly, driven by increasing complex CAD cases and the adoption of surgical technologies. Favorable clinical evidence, particularly in favor of CABG over PCI,…
Report
Coronary Artery Bypass Graft Devices – Market Insights – Europe (Supplemental)
The mature European CABG device market will contract modestly through 2026 as procedure volumes decline due to increasing use of PCI for the treatment of CAD; however, rising interest in …
Report
Coronary Artery Bypass Graft Devices – Market Insights – Europe
The mature European CABG device market will contract modestly through 2026 as procedure volumes decline due to increasing use of PCI for the treatment of CAD; however, rising interest in OPCAB…
Report
Coronary Artery Bypass Graft Devices | Medtech 360 | Market Analysis | US | 2018
The mature US CABG device market will contract slightly through 2026 as procedure volumes decline due to increasing use of PCI for the treatment of CAD; however, rising interest in off-pump…
Report
Peripheral Vascular Devices | Medtech 360 | Market Analysis | Europe (Supplemental) | 2017
The European market for PV devices continues to expand, driven primarily by procedure volume growth in the lower-limb indications and adoption of premium-priced products. This Medtech 360…